Now real hope to end coronavirus with vaccines: World Health Organization chief Ghebreyesus

Moderna to charge Rs 1855-Rs 2755 for COVID-19 vaccine: CEO

U.S. expects to begin COVID-19 vaccinations in early December: reports

Pfizer and Moderna's vaccines have already been shown to be effective, according to company data, and Gates said he expects AstraZeneca, Johnson & Johnson and Novavax's vaccines to have similar success soon.

He said: "With the latest positive news from vaccine trials, the light at the end of this long, dark channel is growing brighter".

Meanwhile, as Brunei will be hosting the ASEAN Summit next year, Dato Seri Setia Dr Haji Mohd Isham said it is very unlikely the nation can host in-person meetings during the first half of the year because the vaccine will only be available during the first quarter of the year. These vaccines, at the point of being administered to the American public, will have more data than any other vaccine developed in history'. Pfizer and its German partner BioNTech and Moderna have each reported vaccines that were 95 percent effective in clinical trials. This is in addition to the 1 billion syringes that need to be transported by sea-freight.

He added that Johnson & Johnson is now working on a one-dose vaccine, which may increase the percentage of people who willing to receive the jab.

"I think we need to wait to see the results both of the efficacy and the safety,"said Swaminathan".

"With a view to having a better supply chain network and distribution of vaccines in a timely manner, three new regional vaccine stores Bengaluru Urban, Shivamogga and Ballari have been proposed", Sudhakar pointed out.

At the same time, Recto aired hopes that "our supply deal with AstraZeneca will push through, as their vaccine matches our wallet [reportedly the cheapest at $10 per person] and our weather [can be stored at home refrigerators]".

AstraZeneca, which has pledged to not make a profit off any jab, has set a price at about $2.50 a dose.

Sinopharm's experimental COVID-19 vaccine uses an inactivated SARS-CoV-2 virus that is unable to replicate in human cells to trigger immune responses.

All three shots must be approved by the FDA before they can be widely distributed. "As long as it's done in a sensible way, there are plenty of issues the USA could work on with China that will suit both of their interests."Blinken would be likely to bring Washington back to its post-war global strategy of advancing American interests by maintaining a world order that is favourable to the U.S. - which would mean a more predictable China policy than under Trump, he said.Lu Xiang, a USA affairs specialist with the Chinese Academy of Social Sciences, said Blinken as secretary of state would be a positive move for Beijing."With his experience, Biden is likely to make some important decisions on foreign policy", Lu said".

Latest News